简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2026-10-12 12:59 Timeline Obtains Court Order Shutting Down Network of Fraudulent “Timeline” Look-Alike Websites
2026-10-12 12:54 Armenia Grants First Marketing Authorizations for Agenus’ BOT+BAL in Previously Treated MSS Metastatic Colorectal Cancer
2026-10-12 11:19 Fall Clinical 2026: Galderma Presents New Three-Year Nemluvio® Data Showing Deep and Lasting Skin Lesion and Itch Responses in Patients With Atopic Dermatitis Aged 12 and Older
2026-10-10 20:19 ClaroNav Kolahi Inc. Announces EU MDR Certification for Navient Surgical Navigation System
2026-10-10 19:00 Medisca and EUROAPI Form Strategic Partnership to Strengthen API Access for Pharmaceutical Compounding
2026-10-10 13:47 Invivoscribe® Advances Molecular Clonality Testing Portfolio with Comprehensive LymphoTrack® Flex Suite
2026-10-10 09:46 30 Years of Restylane®: Reshaping the Aesthetics Field Through Science-Led, Patient-Centric Innovation
2026-10-09 16:00 GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.
2026-10-09 15:53 Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026
2026-10-09 15:49 STI-IR Brings Japan’s 360-Degree Bristle Toothbrush “POPOTAN” to the World
2026-10-09 15:43 Global Health Leaders to Convene at Abu Dhabi Future Health Summit 2026
2026-10-09 14:53 LISTERINE® Launches Oral Care Counts This World Smile Day as Oral Disease Cases Rise to 3.73 Billion
2026-10-09 14:46 Samsung Bioepis and Teva Expand Strategic Partnership to Advance Up to Six Potential Biosimilar Candidates
2026-10-08 16:34 Neutrogena®, Aveeno®, and Regaine® Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and Hair
2026-10-08 15:12 Roquette to Showcase End-to-End Pharma Solutions for Patient-Centric Formulations at CPHI Milan 2026
2026-10-08 14:05 TriLink BioTechnologies® Secures Additional China Patent for CleanCap® Technology, Adding Broad Composition-of-Matter Protection to Reinforce Its Global IP
2026-09-30 15:26 EADV 2026: Galderma’s New Data Show Sustained Improvements with Nemluvio® (nemolizumab) for up to Three Years in Patients With Moderate-to-severe Atopic Dermatitis
2026-09-30 15:23 Zasocitinib Delivered Superior Efficacy Versus Deucravacitinib in New Phase 3 Head-to-Head Results, Reinforcing Potential to Deliver Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill
2026-09-28 15:38 Future Health Convenes Global Health Leaders at UNGA to Advance Health System Transformation at Scale
2026-09-28 11:16 Future Health - A Global Initiative by Abu Dhabi: New Analysis Estimates Modifiable Health Risks Represent $16.4 Trillion Annual Global GDP Opportunity in 2050

Business Wire Weibo

Press Releases

Latest Releases